CIK 0001326110
- Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 431979754
- Phone
- +1 844-696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +65,600 | 65,600 | ||
| 2025-06-18 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +162,786 | 162,786 | ||
| 2024-06-11 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +77,633 | 77,633 | ||
| 2023-06-13 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +158,263 | 158,263 | ||
| 2023-06-01 | Clark Wesley Director | Purchase | +7,000 | $2.91 | $20K | 8,000 |
| 2022-06-14 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +167,937 | 167,937 | ||
| 2021-06-10 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +26,064 | 26,064 | ||
| 2021-05-03 | Clark Wesley Director | Grant or award · Stock Option (right to buy) | +21,873 | 21,873 |
Page 1 of 1 · 8 trades